Bronchial Biopsy Devices Market To Reach $1.02 Billion By 2030

 

The global Bronchial Biopsy Devices Market size is expected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.39% from 2024 to 2030, according to a new report by Grand View Research, Inc. One of the major factors contributing to the growth of the market is the rising utilization of bronchial biopsy devices for diagnosing respiratory diseases and the increasing adoption of disposable devices. Moreover, rapid technological advancements and increasing awareness and screening regarding respiratory diseases also contribute to market expansion.

Advancements in medical technology are significantly driving the growth of the market by improving the precision, safety, and effectiveness of diagnostic procedures. Innovations such as EBUS-TBNA enable more accurate sampling of lung tissue, especially in difficult-to-reach areas. These minimally invasive techniques minimize patient discomfort, reduce the risk of complications, and shorten recovery times compared to traditional surgical methods. In addition, companies are entering the market with technologically advanced products to establish a strong presence. For instance, in May 2021, Olympus launched the BF-UC190F endobronchial ultrasound (EBUS) bronchoscope for lung cancer diagnosis and staging, thereby expanding its product portfolio.

Moreover, the increasing awareness and screening initiatives led by various organizations are significantly driving the demand for bronchial biopsy devices. With lung cancer being one of the most prevalent and deadly forms of cancer globally, organizations such as the American Lung Association and the WHO have intensified their efforts to promote early detection and diagnosis. In August 2024, in recognition of World Lung Cancer Day, the Forum of International Respiratory Societies, with the Global Initiative for Asthma as a founding member, emphasized the critical need for increased awareness, early screening, and improved access to lung cancer diagnosis & treatment.

Furthermore, the COVID-19 pandemic had a moderately negative impact on the bronchial biopsy device market, as evidenced by the disruption in lung cancer diagnosis and treatment observed during the early months of the pandemic. According to a study conducted by Elsevier España SLU, in July 2021, at a referral University Hospital in Spain, the mandatory confinement from March 23rd to June 21st, 2020, led to a substantial decrease in the number of lung cancer diagnoses. This decline was attributed to the cancellation or delay of medical consultations, diagnostic tests, and non-essential procedures, which resulted in a reduced number of lung biopsies & screening visits.

 Request a free sample copy or view report summary: Bronchial Biopsy Devices Market Report

Bronchial Biopsy Devices Market Report Highlights

• Based on product, the transbronchial needle aspiration (TBNA) needles segment held the largest revenue share of 62.18% in 2023 and is expected to register growth at the highest CAGR over the forecast period. Moreover, the cryobiopsy devices (cryoprobes) segment is anticipated to grow significantly over the forecast period
• The EBUS-TBNA segment held the largest market share in 2023, as it is a minimally invasive technique that allows for collecting tissue samples from the lungs and surrounding lymph nodes without requiring major surgery
• In 2023, North America dominated the market with a share of over 40%, owing to the robust healthcare infrastructure and rising adoption of innovative diagnostic tools
• Key players in the market are adopting several strategies such as partnership, collaboration, and product launch to expand their offering and increase their market share. For instance, in May 2024, Cook Medical, introduced AcuCore, a next-generation EchoTip AcuCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S. It is employed with an ultrasound endoscope for FNB of extramural and submucosal lesions lymph nodes, mediastinal masses, and intraperitoneal masses within the GI tract

Bronchial Biopsy Devices Market Segmentation

Grand View Research has segmented the global bronchial biopsy devices market based on product and region:

Bronchial Biopsy Devices Product Outlook (Revenue, USD Million, 2018 - 2030)

• Biopsy Forceps
• Durability

• Disposable
• Reusable
• Transbronchial Needle Aspiration (TBNA) Needles
• Conventional
• EBUS-TBNA
• Cytology Brushes
• Cryobiopsy Devices (Cryoprobes)
• Durability
• Disposable
• Reusable

Bronchial Biopsy Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• Italy
• France
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Kuwait

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Germany Pharmaceuticals Market Size Worth $65.9 Billion By 2027

 The Germany Pharmaceuticals Market size is expected to reach USD 65.9 billion by 2027, expanding at a CAGR of 6.0%, according to a new report by Grand View Research, Inc. Factors such as the rising prevalence of acute and chronic diseases and increasing R&D expenditure by pharmaceutical companies are expected to drive the market.

Furthermore, rising clinical trials and approval of novel immune-suppressive therapies are anticipated to propel market growth. For instance, in June 2020, Sandoz International GmbH launched Dailiport capsules (generic tacrolimus) in Germany and other European countries. Dailiport capsules are indicated for adult kidney and liver transplant patients.

In addition, the export of pharmaceutical products by pharmaceutical companies in Germany to various countries is expected to fuel market growth. For instance, according to Germany Trade and Invest, in China, 22.0% of imported pharmaceutical products are from German companies.

Key players entering into strategic initiatives such as partnership, licensing, acquisition, and collaboration to expand and strengthen their regional presence is expected to boost the market growth. For instance, in November 2019, Bristol-Myers Squibb Company acquired Celgene Corporation. This acquisition was aimed at helping the company expand its oncology portfolio worldwide and develop innovative medicines.

In addition, rising funds by organizations for the development of pipeline drugs are anticipated to accelerate market growth. For instance, in January 2019, Atriva Therapeutics GmbH closed its series A financing led by Meneldor and High-Tech Gründerfonds GmbH (HTGF) for its lead drug candidate ATR-002. This drug candidate is developed against influenza infection and other respiratory infections.

Various other organizations, such as the European Cancer Organisation (ECCO), European Cancer Patient Coalition (ECPC), and European Organisation for Research and Treatment of Cancer (EORTC) provide funds for cancer research programs and treatment plans.

Furthermore, increasing the availability of generic drugs at a lower price is expected to boost the market growth. For instance, in July 2019, Sandoz of Novartis AG launched a generic version of gefitinib for locally advanced or metastatic NSCLC. The launch of the generic version is estimated to increase the number of patients treated due to the favorable cost of the drug.

List of Key Players of Germany Pharmaceuticals Market

• Boehringer Ingelheim International GmbH
• Bayer AG
• Merck & Co., Inc.
• Fresenius Kabi AG
• STADA Arzneimittel AG
• Pfizer Inc.
• Abbott
• Abbvie Inc.
• Teva Pharmaceutical Industries Ltd.
• Novartis AG
• Sanofi
• Johnson & Johnson Services, Inc.
• GlaxoSmithKline plc
• AstraZeneca
• Celgene Corporation
• Amgen Inc.
• Novo Nordisk A/S
• Eli Lilly and Company
• Allergan

Request a free sample copy or view report summary: Germany Pharmaceuticals Market Report

Germany Pharmaceuticals Market Report Highlights

• In 2019, anti-cancer was the largest-revenue holding drug class in the market owing to rising approval of new drugs and increasing research studies on new approaches to treating various cancers
• Immunosuppressant product type is estimated to be the fastest-growing drug class during the forecast period owing to rising development and launch of novel immunosuppressant
• Oncology application held the largest revenue share in 2019 due to the increasing prevalence of breast cancer, prostate cancer, and lung cancer
• On the basis of type, the generic drugs segment is expected to be the fastest-growing segment over the forecast period due to its cost-effectiveness and expiration of patents.

Germany Pharmaceuticals Market Segmentation

Grand View Research has segmented the Germany pharmaceuticals market on the basis of drug class, application, type, and formulation:

Germany Pharmaceuticals Drug Class Outlook (Revenue, USD Million, 2016 - 2027)

• Anti-cancer
• Anti-diabetics
• Anti-rheumatics
• Vaccines
• Anti-viral
• Immunosuppressant
• Bronchodilators
• Dermatological
• Anti-hypertensive
• Others

Germany Pharmaceuticals Application Outlook (Revenue, USD Million, 2016 - 2027)

• Oncology
• Breast cancer
• Lung cancer
• Colorectal cancer
• Ovarian cancer
• Prostate cancer
• Others
• Infectious Diseases
• Cardiovascular Diseases
• Central Nervous System Disorders
• Immunological Disorders
• Metabolic Disorders
• Gastrointestinal Disorders
• Respiratory Diseases
• Ophthalmology
• Dermatology Disorders
• Others

Germany Pharmaceuticals Type Outlook (Revenue, USD Million, 2016 - 2027)

• Branded
• Generics

Germany Pharmaceuticals Formulation Outlook (Revenue, USD Million, 2016 - 2027)

• Solid formulation
• Tablets
• Capsules
• Others
• Liquid & semi-liquid formulation
• Oral
• Topical
• Sublingual and buccal
• Rectal
• Parenteral

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Life Sciences Translation Services Market Size is Predicted to Witness 8.43% CAGR till 2030

 

The global Life Sciences Translation Services Market size is anticipated to reach USD 2.55 billion by 2030 and is projected to grow at a CAGR of 8.43% during the forecast period, according to a new report by Grand View Research, Inc. The demand for life sciences translation services is driven by increasing globalization, digitizing of content, and personalized international customer service.

AI is advancing the market by enhancing translation accuracy and efficiency through the automated processing of complex medical and scientific documents. AI-driven tools facilitate faster, more reliable translations, supporting global research and regulatory compliance. Hence, market players are introducing AI-based translation solutions. For instance, in August 2023, Vital launched an AI-powered translator designed to convert complex medical terminology into plain language. Utilizing large language models and natural language processing, this tool translates intricate medical documents, including doctor’s notes, radiologist reports, discharge summaries, and test results, into text understandable at a 5th-grade reading level.

In North America, the market is driven by the region's extensive pharmaceutical and biotechnology industries, which require precise and compliant translations for clinical trials, regulatory submissions, and patient information. The increasing emphasis on regulatory compliance, coupled with the need to support a diverse patient population and facilitate global market access, fuels demand for accurate translation and localization services. In addition, the growth of international collaborations and research initiatives further contributes to the need for specialized translation services in this sector.

The market is experiencing a number of mergers and acquisitions as companies seek to boost their market position. For instance, in October 2022, Acolad Life Sciences partnered with Alphanumeric to support life sciences organizations with their international communication needs, including over-the-phone interpreting (OPI) for global call centers. 

List of Key Players in the Life Sciences Translation Services Market

• Vistatec
• Language Scientific
• marstranslation
• BayanTech.
• Lionbridge Technologies, LLC.
• Conversis
• Morningside, Inc
• Crimson Interactive Inc.
• Welocalize Life Sciences
• ALM Translations Ltd
• Stepes
• Questel.
• BURG Translations

Request a free sample copy or view report summary: Life Sciences Translation Services Market Report

Life Sciences Translation Services Market Report Highlights

• In terms of type, the technical translation segment dominated the market with the largest revenue share in 2023. The growth is attributed to the growing need for precise and specialized translation of complex scientific and technical documents.
• Based on category, the technology/AI-based segment dominated the market with the largest revenue share in 2023 and is expected to grow at the fastest CAGR during the forecast period. The AI and machine learning-based advanced technologies enhance the efficiency and accuracy of translations by automating complex processes and adapting to diverse linguistic needs.
• Based on end use, the Clinical Research Organizations (CRO) segment dominated the market with the largest revenue share in 2023 and is anticipated to register the fastest growth rate during the forecast period. The growth is attributed to its critical role in managing clinical trials, regulatory submissions, and global research activities.
• North America dominated the market in 2023, owing to the presence of diverse populations, increasing number of clinical trials, and growing demand for regulatory compliance.
• In April 2024, TransPerfect partnered with Healthy Birth Day, Inc. to provide digital health translation technology and services to enhance the organization's translation capabilities. Healthy Birthday, a women-founded nonprofit, focuses on enhancing birth outcomes through research, programming, and advocacy.

Life Sciences Translation Services Market Segmentation

Grand View Research has segmented the global life sciences translation services market based on type, category, end use, and region.

Life Sciences Translation Services Type Outlook (Revenue, USD Million, 2018 - 2030)

• Clinical/Document Translation
• Technical Translation
• Labeling and Device Translation
• Corporate/Marketing Translation

Life Sciences Translation Services Category Outlook (Revenue, USD Million, 2018 - 2030)

• Manual
• Technology/AI-Based

Life Sciences Translation Services End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical Manufacturers
• Biotechnology Companies
• Medical Device Manufacturers
• Clinical Research Organizations
• Others

Life Sciences Translation Services Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East and Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

 

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com

Hyperpigmentation Treatment Market To Reach $2.02 Billion By 2030

 The global Hyperpigmentation Treatment Market size is expected to reach USD 2.02 billion by 2030, registering a CAGR of 6.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing awareness about skin health and the rising demand for aesthetic improvements are key drivers. Technological advancements in non-invasive treatments, such as laser therapy, chemical peels, and micro needling, have made hyperpigmentation treatments more effective and accessible. Additionally, the growing influence of social media and beauty influencers has heightened consumer awareness and desire for immaculate skin, encouraging more people to seek professional treatments. The expansion of dermatology clinics and aesthetic centers offering specialized services further supports this market growth, as more consumers are willing to invest in maintaining a youthful and radiant complexion.

Moreover, rapid advancement in aesthetic treatment technologies, innovations in laser therapy, chemical peels, microneedling, and other non-invasive procedures have significantly improved the effectiveness and safety of hyperpigmentation treatments. For instance, technologies like intense pulsed light (IPL) and fractional laser treatments offer targeted solutions with minimal downtime, attracting a broad range of consumers. Developing advanced topical treatments, such as brightening serums and creams infused with potent active ingredients, also provides non-invasive options for managing hyperpigmentation, catering to consumers' diverse preferences.

In addition, rising disposable incomes and changing lifestyle patterns contribute to the market's expansion. As more consumers gain the financial capability to invest in aesthetic procedures, the demand for hyperpigmentation treatments continues to rise. The trend is particularly evident in emerging markets, where an increasing focus accompanies economic growth on personal grooming and skincare. Additionally, cultural factors that emphasize the importance of clear and even-toned skin further fuel the demand for hyperpigmentation treatments in these regions.

List of Key Players in the Hyperpigmentation Treatment Market

• Sedgh Plastic Surgery
• Dermatologikum Berlin
• Skin Deep Laser Services
• Medical Beauty Cologne
• Dermatology Private Clinic Dr. med. Aresu Naderi
• The Harley Street Dermatology Clinic
• Premier Laser Clinic UK Ltd.
• Qazi Cosmetic Center
• ABBY SKIN CLINIC
• The Marbella Vein & Beauty Clinic

Request a free sample copy or view report summary: Hyperpigmentation Treatment Market Report

Hyperpigmentation Treatment Market Report Highlights

• The age spots segment dominated the market and held the largest revenue share of 36.6% in 2024. The melasma segment is expected to grow at the fastest CAGR of 7.1% from 2025 to 2030.
• The energy-based therapy segment dominated the market and held the largest revenue share of 68.4% in 2024. The microneedling segment is expected to grow at the fastest CAGR of 6.7% from 2025 to 2030.
• The Fitzpatrick skin type III & IV segment dominated the market and held the largest revenue share of 39.6% in 2024. This dominance is attributed to the higher prevalence of hyperpigmentation disorders in individuals with these skin types.
• The dermatology clinics segment dominated the market with a revenue share of 49.4% in 2024. This dominance is attributed to the high level of trust and expertise associated with dermatology clinics, making them the preferred choice for patients seeking professional and effective hyperpigmentation treatments.

Hyperpigmentation Treatment Market Segmentation

Grand View Research has segmented global hyperpigmentation treatment market report based on indication, treatment, skin tone, end-use, and region:

Hyperpigmentation Treatment Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Age spots
• Melasma
• Post-inflammatory hyperpigmentation (PIH)
• Others

Hyperpigmentation Treatment Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Energy-based Therapy
• Laser
• Intense Pulse Light (IPL)
• Others
• Chemical Peels
• Microdermabrasion
• Microneedling

Hyperpigmentation Treatment Skin Tone Outlook (Revenue, USD Million, 2018 - 2030)

• Fitzpatrick skin type I & II
• Fitzpatrick skin type III & IV
• Fitzpatrick skin type V & VI

Hyperpigmentation Treatment End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Dermatology Clinics
• Aesthetic Centers
• Hospitals & Specialty Clinics

Hyperpigmentation Treatment Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Italy
• Spain
• Denmark
• Sweden
• Norway
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Thailand
• Latin America
• Brazil
• Argentina
• Middle East & Africa (MEA)
• South Africa
• Saudi Arabia
• UAE
• Kuwait

 

 

About Us:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com